Keeping you in the know on the constantly changing world of medical billing and reimbursement, Quadax compiles industry news and articles covering important revenue cycle topics impacting the lab industry.
Not already a subscriber? Enter your email here to receive industry news, insights, and updates right to your inbox.
14 insurers extending COVID-19 cost-sharing waivers into 2021
Several commercial health insurers will waive member cost-sharing — which includes copays, deductibles and coinsurance — for COVID-19 testing and treatment into the next year.
CDC Offers New COVID-19 Specimen Collection Infographics
CDC recently published two new infographics for performing nasopharyngeal (NP) and nasal mid-turbinate (NMT) specimen collection in the Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens for COVID-19. Healthcare providers can use these infographics as a resource when collecting specimens for COVID-19 testing.
Surging COVID-19 Cases Are Pushing Laboratories to the Breaking Point
Long lines for testing. Shortages of critical testing supplies. Case backlogs and long reporting delays. Do laboratories have the capacity to keep up with testing demands?
Insurers, labs point fingers over COVID-19 test coverage, prices
The Families First Coronavirus Response Act and the Coronavirus Aid, Relief, and Economic Security Act both included provisions ensuring that people can receive COVID-19 tests without out-of-pocket costs. However, ACLA says "murky" regulatory guidance issued in June by HHS, Labor and Treasury is driving coverage denials and high costs.
COVID-19 and in vitro diagnostics: New market forces at play
The high demand for in vitro diagnostics could seed structural shifts that will have long-term implications for diagnostic-test manufacturers.
‘Nobody Sees Us’: Testing-Lab Workers Strain Under Demand
Laboratory technologists have been working nonstop to help the nation diagnose an ever-growing number of coronavirus cases.
New assay offers rapid SARS-CoV-2 antibody testing
Researchers have developed a new blood assay that uses optical biosensor technology to test for SARS-CoV-2 antibodies in under 20 minutes, according to a study published on December 10 in Scientific Reports.
What have labs learned from the COVID-19 pandemic?
If you had the chance to do it all over again, what would you do differently? Representatives from clinical labs pondered that question as it relates to the COVID-19 pandemic in a December 14 session at the American Association for Clinical Chemistry (AACC) virtual meeting, offering guidance on how labs could respond to the next global health emergency.
Centers for Medicare and Medicaid Services (CMS)
Congresswoman Terri Sewell, D-Alabama, joined three other lawmakers in introducing bipartisan legislation to remove barriers to innovative multi-cancer screening technology for Medicare beneficiaries. The bill would ensure prompt access to FDA-approved multi-cancer screening tests and fuel innovation in cancer screening.
2020 MIPS Extreme and Uncontrollable Circumstances Exception Deadline Extended
The CMS extended the 2020 Merit-based Incentive Payment System (MIPS) Extreme and Uncontrollable Circumstances Exception application deadline to February 1, 2021. For pathologists, physicians, and other clinicians who are unable to meet requirements for MIPS in 2020 due to COVID-19, the CMS will allow you to request a hardship exception. The CAP has advocated for MIPS reporting relief for pathology practices in light of the pandemic.
CAP Pushes Congress to Stop Medicare Cuts in Year-End Spending Deal
With Congress maneuvering to complete its year-end business before the holidays, the CAP lobbied congressional lawmakers and staff to stop -9% Medicare cuts to pathologists in 2021. Progress has been made with gaining support amongst lawmakers to stop or mitigate the cuts to pathologists and other specialty physicians next year.
CMS Proposes New Rules to Address Prior Authorization and Reduce Burden on Patients and Providers
The Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that would improve the electronic exchange of health care data among payers, providers, and patients, and streamline processes related to prior authorization to reduce burden on providers and patients.
HHS announced proposed changes to the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule to support individuals’ engagement in their care, remove barriers to coordinated care, and reduce regulatory burdens on the health care industry.
The HIPAA Information Access Rights Crackdown Continues
As of September 2019, no provider had ever been fined for failing to meet their PHI access responsibilities. Now, nearly a dozen such fines have been imposed. And those numbers are growing literally every week. Here’s the latest rundown of settlements.
Bayer and Tempus are partnering to provide broader access to genomic testing and tailored treatment approaches for the oncology community. They plan to help facilitate patient identification for precision oncology by providing testing via the Tempus xT broad-panel genomic sequencing assay.
House and Senate committee leaders reached a pivotal deal to end surprise medical bills and hope to include it in an end-of-year spending package. The deal would prohibit certain out-of-network providers from balance billing patients unless the patient is notified of their network status.
In response to the COVID-19 public health emergency, we are delaying implementation of the Laboratory Test Registry Protocol to January 1, 2022.